Skip to main content
Clinical Trials/NL-OMON39359
NL-OMON39359CompletedPhase 3

The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gait - Botulinum toxin type A injections in stiff knee gait

Revalidatiecentrum Het Roessingh0 sites26 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
26

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • age over 18 years
  • 6 months post stroke
  • patient walks with a stiff knee gait caused by an overactivity of the m. rectus femoris
  • able to walk independent
  • overactivity of the m. rectus femoris, established with EMG-measures

Exclusion Criteria

  • presence of other constraints in joints who impede walking
  • neurological problems not causes by a Cerebro Vascular Accident
  • patient walks with a diminished knee flexion as a result of an orthopedic cause
  • myasthenia gravis or Eaton-Lambert syndrome
  • progressive clinical picture which influence the gait pattern
  • use of amfotericine B en/of amsacrine
  • pregnancy / nursing mothers

Investigators

Sponsor
Revalidatiecentrum Het Roessingh

Similar Trials